The bankruptcy of genetic-testing pioneer 23andMe is a powerful cautionary tale. After going public in 2021 with a $3.5 billion valuation, the company’s market cap plummeted to less than $13.5 million ...
That's what a team of scientists in the Czech Republic did this year to celebrate Gregor Mendel, a scientist and friar whose experiments in the mid-1800s laid the groundwork for modern genetics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback